2016 prospectus/DD Summary
Calendar Q1-2016 (January 1
2016 prospectus/DD Summary
Calendar Q1-2016 (January 1 – March 31)
• Implement enhanced corporate visibility strategy (Done)Also, concurrent with the close of financing, the Company is announcing that independent director Daniel Carlson has assumed the role of Chairman, taking over from company CEO and Director, Stephen A. Squires. “As we look to position Quantum Materials for a potential uplisting to a major exchange,
• Gain one or more financial industry research coverage/analyst reports (???? Vista was announced in early December.) Roth Capital Partners
• Complete one or more strategic partnerships (????)
January 27, 2016 Quantum Materials Corp to Launch Quantum Dot Production in China,Joint Venture Partner GTG Commits $20 Million US Investment for building out Quantum Materials QDX™ quantum dot production facilities and quantum dots application development.
• Convert one or more existing MTA relationships to funded joint development agreements (JDA) (???? No new JDA announcements.)
(MTA – Material Transfer Agreement JDA – Joint Development Agreement) Nitto Denko Uniglobe Kisco do not have details yet
Calendar Q2-2016 (April 1 – June 30)
• Complete commercial design of cadmium-free quantum dot film for OEM display panel industry (with partner) (???? Still in "optimization" mode according to recent press release.) We're still in Q2
• Complete commercial design of cadmium quantum dot film for OEM display panel industry (with partner) (????) Nitto Denko Uniglobe Kisco No Details yet
• Expand product offering to introduce nano-material solutions for broader opto-electronics markets (????) Nitto Denko Uniglobe Kisco No Details yet
Calendar Q3 2016 (July 1 – September 30)
Begin generating revenues from quantum dot material sales
Establish offshore manufacturing capacity
Calender Q4 (October 1 – December 31)
Accelerate optimization of quantum dot solar cell
Double existing quantum dot production
capacity to 4+ metric tons/year
Increase I.P. portfolio
Up list the Company to NASDAQ
6 years of DD in a few paragraphs
Lets first of all forget anything prior to Star Park besides the Access2Flow for continuous flow and of course Rice and Arizona licensing agreements.
Star Park has allowed QMC to expand their production as demonstrated to the Chinese Investors and I am confident others. They also bought the Bayer Licenses for patent protection and now have Dr. Nathan Stott as they continue to perfect their Cadmium Free QDX.
In their prior history they have never mentioned significant revenue till April of this year. They have never mentioned Exchange upgrade till their 2016 overview. Steve needs to oversee QMC Asia operation as they install a reactor in China which Leaves Daniel Carlson to help with the exchange upgrade and Sri Peruvemba our newly appointed CEO to secure the Display and LED market he is considered one of the leading authorities in the industry.
QMC is past the sample stage with Nitto Denko (and possibly unnamed others) and increase shipment quantities as development reaches pre-commercial scale later this year along with being warmly accepted by Uniglobe Kisko at display week along with (unnamed related to 40 NDA's). QMC is expecting full production as we approach 2017.
These are All positive steps, Investors should do well, QMC has done there homework and ready to emerge as a major supplier of Quantum dots for many different applications. IMO you can take that to the bank. glta.
3
Quantum Materials Corp. (QTMM) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....
Continue Reading
Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...
Continue Reading
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...
Continue Reading
Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...
Continue Reading
Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...
Continue Reading
Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....
Continue Reading
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Apax Global Alpha Limited Apax Global Alpha Limited is a prominent player in the investment sector, recognized for its strategic engagements and robust portfolio. The company, trading under the ticker LSE:INVP, has continuous operations, which not only aim at capital growth but also seek to provide substantial value to stakeholders. Key Information Overview...
Continue Reading
Morgan Stanley's Updated Ratings on European Oil and Gas Stocks Morgan Stanley has recently updated its ratings on several notable European oil and gas companies, showcasing a mixed but insightful outlook for the sector as we head into 2025. The analysts have raised their overall view of the industry from a cautious stance to 'in-line,' reflecting compelling valuations...
Continue Reading
Defense Metals Corp Successfully Completes Private Placement Defense Metals Corp. (TSXV: DEFN) is excited to announce the closing of the second and final tranche of its private placement, designed to enhance its financial stability and operational capabilities. This recent tranche has brought in gross proceeds amounting to C$576,000, a notable addition to the ongoing...
Continue Reading
Overview of the Securities Fraud Class Action The latest class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE) has raised significant concerns among investors. Recently announced, this lawsuit claims violations of federal securities laws amidst a notable decline in stock value, spurred by an impairment charge of $323.9 million. Implications of the...
Continue Reading
Czech Central Bank's Potential for Rate Easing The Czech central bank finds itself at a pivotal moment as it considers resuming its monetary easing strategy, potentially as soon as next month. Board member Jan Prochazka has shed light on these developments, emphasizing that while easing could be on the table, uncertainties loom due to various domestic and external...
Continue Reading